Clinical Trials Directory

Trials / Completed

CompletedNCT02005601

Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

We are investigating the impact of duloxetine ("Cymbalta"), a serotonin and norepinephrine reuptake inhibitor, on pain after total knee arthroplasty (TKA). Specifically, the investigators will determine whether duloxetine, 60 mg daily for 2 weeks, reduces pain scores 2 weeks after TKA.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboPatients will receive placebo drug with no active ingredients per dose. 1 capsule will be taken pre-operatively. One capsule once a day until end of POD14.
DRUGDuloxetine 60mgPatients will receive 60mg of duloxetine per dose. 1 capsule will be taken pre-operatively. One capsule once a day until end of POD14.

Timeline

Start date
2013-11-01
Primary completion
2015-05-01
Completion
2015-08-01
First posted
2013-12-09
Last updated
2017-08-29
Results posted
2017-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02005601. Inclusion in this directory is not an endorsement.

Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty? (NCT02005601) · Clinical Trials Directory